Philly Xarelto Suits Combined Into Mass Tort Program

Law360, Philadelphia (January 21, 2015, 1:24 PM EST) -- The top administrative judge in Philadelphia County Court of Common Pleas has created a new mass tort program to consolidate a slew of product liability cases over Johnson & Johnson unit Janssen Pharmaceuticals Inc. and Bayer Corp.'s blood thinner Xarelto, according to an order docketed Tuesday.

Administrative Judge Kevin Dougherty signed off on the request, which was filed by two of the six firms currently representing Xarelto plaintiffs. As of Jan. 14, 73 cases have been filed in the court alleging that the medication, designed as a replacement for warfarin, has caused severe internal bleeding.

"We anticipate a significant number more,"...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Beta
Ask a question!